RegentAtlantic Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.18M | Sell |
14,226
-1,779
| -11% | -$147K | 0.04% | 281 |
|
|
2022
Q2 | $1.52M | Buy |
16,005
+2,569
| +19% | +$244K | 0.05% | 243 |
|
|
2022
Q1 | $1.58M | Buy |
13,436
+1,813
| +16% | +$213K | 0.04% | 251 |
|
|
2021
Q4 | $1.51M | Buy |
11,623
+2,036
| +21% | +$264K | 0.04% | 257 |
|
|
2021
Q3 | $1.09M | Buy |
9,587
+1,036
| +12% | +$117K | 0.03% | 288 |
|
|
2021
Q2 | $886K | Buy |
8,551
+4,583
| +115% | +$475K | 0.03% | 313 |
|
|
2021
Q1 | $332K | Buy |
3,968
+1,450
| +58% | +$121K | 0.01% | 452 |
|
|
2020
Q4 | $230K | Buy |
+2,518
| New | +$230K | 0.01% | 465 |
|
|
2015
Q1 | – | Sell |
-858
| Closed | -$18.2K | – | 531 |
|
|
2014
Q4 | $18.2K | Buy |
+858
| New | +$18.2K | ﹤0.01% | 781 |
|